NVDA+0.84%AAPL−2.51%GOOGL−1.17%MSFT−2.04%AMZN−0.15%TSM+2.85%SPCX−1.20%AVGO+0.21%
StockVS

NASDAQ · Medical Instruments & Supplies · USD

KORU Medical Systems, Inc. (KRMD) Stock Analysis

KORU Medical Systems, Inc. (KRMD) is a Medical Instruments & Supplies stock listed on NASDAQ and quoted in US Dollar.

KRMD

$3.25

+$0.03 (+0.93%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare KRMD with… →

KRMD Key Statistics

As of Sep 4, 2026
Trading
Open
$3.22
Previous Close
$3.22
Day's Range
3.16–3.30
52-Week Range
3.14–6.61
Volume
116.60K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
0.42
Valuation
Market Cap
$149.28M
P/E Ratio
unprofitable
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
92.86
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
3.31
EPS (ttm)Profit attributable to each share over the last twelve months.
−0.04
Financials (FY)
Revenue (FY)
$41.13M+22.23%
Net Income (FY)
−$2.64M
Profit marginThe share of revenue left as profit after all costs and taxes.
−4.03%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
45.93M
1-Year Return
−20.73%
Dividend and dates
Earnings Date
November 11, 2026
Avg Volume
196.29K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

KRMD Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−44.06%
2025+50.91%
2024+56.82%
2023−31.23%
2022+19.00%
2021−50.17%
2020−7.81%
2019+295.76%
2018+32.00%
2017+150.00%
2016 (partial year)+8.70%

As of September 4, 2026.

KRMD Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$41.13M−$2.64M−6.4%
2024$33.65M−$6.07M−18.0%
2023$28.52M−$13.74M−48.2%
2022$27.90M−$8.66M−31.0%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$41.13M$25.60M−$2.97M−$2.64M−6.4%
2024$33.65M$21.33M−$6.45M−$6.07M−18.0%
2023$28.52M$16.71M−$10.27M−$13.74M−48.2%
2022$27.90M$15.37M−$10.78M−$8.66M−31.0%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

KRMD Valuation vs Medical Instruments & Supplies Median

Median of 55 stocks
MetricKRMDMedical Instruments & Supplies medianvs median
P/S ratio3.313.174% above
Profit margin−4.03%0.85%4.9 pts below

Medians across 55 Medical Instruments & Supplies stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

All 13 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

KORU Medical Systems, Inc. (KRMD) is capitalised at $149.28M on the latest close. The company sits in the Healthcare sector, in the Medical Instruments & Supplies industry. Headcount on file is 73.

The most recent close on file for KRMD is $3.25, dated September 4, 2026. That is +$0.03 (+0.93%) against the previous close. Over the past 52 weeks the price has ranged from $3.14 to $6.61. The latest close sits 3.5% above that 52-week low.

Financial Health

In fiscal 2025, KORU Medical Systems, Inc. reported revenue of $41.13M. That is +22.23% against the prior fiscal year, when revenue was $33.65M. The same year closed with a net loss of $2.64M. Profit margin runs at −4.03%. That is 4.9 percentage points below the Medical Instruments & Supplies median of 0.85%. Earnings per share on a trailing basis come to −0.04.

Across the 4 fiscal years on file, revenue moves from $27.90M in 2022 to $41.13M in 2025. Of those 4 years, 0 report positive net income.

Valuation Assessment

No trailing P/E applies: the last reported earnings figure is negative. On forward earnings the ratio is 92.86. Measured against sales, the shares trade at 3.31 times revenue. On price-to-sales that is 4.31% above the Medical Instruments & Supplies median of 3.17. The medians here are taken across 55 Medical Instruments & Supplies companies that report the metric.

The reported beta is 0.42. Annualized volatility over the trailing 10 years is 68.07%. Over the trailing twelve months the price has returned −20.73%. Across 10 years the annualized return works out at +21.86%.

Growth & Income

No dividend is on file for KRMD.

So far in 2026 the price is −44.06%. Across the complete calendar years on file, 2019 returned +295.76% and 2021 returned −50.17%. Of the 9 complete calendar years on file, 6 finished higher.

Peer Comparison

KORU Medical Systems, Inc. (KRMD) operates in the Medical Instruments & Supplies industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
KORU Medical Systems, Inc. KRMD $149.28M —
Intuitive Surgical, Inc. ISRG $131.38B 42.4
Becton, Dickinson and Company BDX $50.32B 32.0
Medline Inc. MDLN $49.23B 45.7

The Medical Instruments & Supplies industry average P/E ratio is 35.6x. KORU Medical Systems, Inc. has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Medical Instruments & Supplies Stocks

ISRG

Intuitive Surgical, Inc.

$131.38B

 BDX

Becton, Dickinson and Company

$50.32B

 MDLN

Medline Inc.

$49.23B

 ALC

Alcon Inc.

$34.08B

 RMD

ResMed Inc.

$32.94B

 WST

West Pharmaceutical Services, Inc.

$23.93B
View all Medical Instruments & Supplies stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.02T

 JNJ

Johnson & Johnson

$663.28B

 ABBV

AbbVie Inc.

$453.19B

 MRK

Merck & Co., Inc.

$370.89B

 UNH

UnitedHealth Group Incorporated

$356.47B
View all Healthcare stocks →

About KORU Medical Systems, Inc.

KORU Medical Systems, Inc. develops, manufactures, and commercializes subcutaneous infusion solutions primarily for the subcutaneous drug delivery market in the United States and internationally. The company offers the FREEDOM infusion systems to deliver therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD), chronic inflammatory demyelinating polyneuropathy (CIDP), secondary immunodeficiency disorder (SIDD), and paroxysmal nocturnal hemoglobinuria (PNH). Its products include the FREEDOM60 Syringe Driver, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company was formerly known as Repro Med Systems, Inc. and changed its name to KORU Medical Systems, Inc. in March 2022. KORU Medical Systems, Inc. was incorporated in 1980 and is headquartered in Mahwah, New Jersey.

Visit website →